Due to the limitations of tumor tissue, some circulating biomarkers have been explored, such as tissue polypeptide-specific antigen(TPS), carcinoembryonic antigen(CEA) and carbohydrate antigen 15.3(CA 15.3), which unfortunately are not sensitive enough to be widely used in clinical practice (23–25). Here, CEACAM5 is linked to neoplasm.